In silico modeling predicts drug sensitivity of patient-derived cancer cells.

In silico modeling predicts drug sensitivity of patient-derived cancer cells.

Item
http://www.wikidata.org/entity/Q33646338
S100A4 and its role in metastasis – computational integration of data on biological networks.Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.Personalization of cancer treatment using predictive simulationIn vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells.A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.Computational modeling in glioblastoma: from the prediction of blood-brain barrier permeability to the simulation of tumor behavior.Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective
P2860

In silico modeling predicts drug sensitivity of patient-derived cancer cells.

Item
http://www.wikidata.org/entity/Q33646338
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@ast
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@en
type
label
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@ast
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@en
prefLabel
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@ast
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
In silico modeling predicts drug sensitivity of patient-derived cancer cells.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932